ÂÜÀòÂÒÂ×

Bob Nyen is an experienced Pharmaceutical Executive with over 20 years of expertise in leading North American and global organizational and portfolio strategies from concept to commercialization. They have a proven track record of driving profitable growth by aligning cross-functional global teams to achieve strategic objectives. Currently, Bob serves as the VP of Strategy, BD&L, Marketing, and Commercial Operations at Cipla Therapeutics, where they lead the development and transformation of biotech and specialty platforms. Previously, Bob held roles at Sanofi and PAREXEL, focusing on commercial strategy and market access. Bob is pursuing a BBA at the University of North Texas and has completed executive education at Wharton.